|
|
|
Corporate Profile: TenX Biopharma
| Summary: |
TenX Biopharma is focused on the development of products to treat cutaneous T-cell lymphoma, peripheral T-cell lymphoma, metastatic melanoma and metastatic renal cell carcinoma.
|
| Address: |
109 N. Orianna St.
Philadelphia, PA 19106 |
| Phone
#'s: |
| Main |
(267) 479-0538 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax
#'s: |
| Main |
(267) 479-0535 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| not known |
| Internet
job postings: |
| not known |
| Number
of employees: |
| not known |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
